A detailed history of Clear Street Markets LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Clear Street Markets LLC holds 500 shares of PRTA stock, worth $10,035. This represents 0.0% of its overall portfolio holdings.

Number of Shares
500
Previous 1,000 50.0%
Holding current value
$10,035
Previous $36,000 66.67%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$24.75 - $40.66 $12,375 - $20,330
-500 Reduced 50.0%
500 $12,000
Q4 2023

Feb 13, 2024

BUY
$32.31 - $52.32 $32,310 - $52,320
1,000 New
1,000 $36,000

Others Institutions Holding PRTA

About PROTHENA CORP PUBLIC LTD CO


  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $942M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Clear Street Markets LLC Portfolio

Follow Clear Street Markets LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Street Markets LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clear Street Markets LLC with notifications on news.